(Q35897969)

11 August 2017

1 reference

title

Medical treatment of glomerular diseases (English)

1 reference

11 August 2017

N. M. Simon

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A153991

13 May 2022

M. J. Rosenberg

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A153991

13 May 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=153991

13 May 2022

publication date

1 November 1978

1 reference

full work available at URL

11 August 2017

https://api.elsevier.com/content/article/PII:S0025712516317321?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31732-1

https://api.elsevier.com/content/article/PII:S0025712516317321?httpAccept=text/plain

13 May 2022

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31732-1

Medical Clinics of North America

13 May 2022

published in

1 reference

11 August 2017

volume

62

1 reference

11 August 2017

issue

6

1 reference

11 August 2017

page(s)

1157-1181

1 reference

Controlled trial of azathioprine in children with nephrotic syndrome. A report for the international study of kidney disease in children

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931732-1

7 January 2021

Rapidly Progressive Glomerulonephritis Treated With Anticoagulants

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931732-1

7 January 2021

Treatment of nephrosis with prednisolone

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931732-1

7 January 2021

Rapidly progressive (nonstreptococcal) glomerulonephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931732-1

7 January 2021

The long-term course of poststreptococcal glomerulonephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931732-1

7 January 2021

Poststreptococcal glomerulonephritis. A progressive disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931732-1

7 January 2021

Controlled trial of cyclophosphamide in steroid-sensitive relapsing nephrotic syndrome of childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931732-1

7 January 2021

Comparative trial of 2 weeks and 8 weeks cyclophosphamide in steroid-sensitive relapsing nephrotic syndrome of childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931732-1

7 January 2021

Idiopathic crescentic glomerulonephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931732-1

7 January 2021

FINDINGS SUGGESTIVE OF A PULMONARY ALVEOLAR-CAPILLARY BLOCK SYNDROME IN A PATIENT WITH CHRONIC LYMPHOCYTIC LEUKEMIA

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931732-1

7 January 2021

Recurrence of mesangial deposition of IgA after renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931732-1

7 January 2021

Controlled trial of prednisone in adult patients with the nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931732-1

7 January 2021

Immunosuppressive therapy in adults with proliferative glomerulonephritis. Controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931732-1

7 January 2021

Combined immunosuppression and anticoagulation in rapidly progressive glomerulonephritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931732-1

7 January 2021

The Effect of Long Term High Dose Heparin Treatment on the Course of Chronic Proliferative Glomerulonephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931732-1

7 January 2021

Bright's Disease Today: The Pathogenesis and Treatment of Glomerulonephritis--I

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931732-1

7 January 2021

Treatment of glomerulonephritis by drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931732-1

7 January 2021

Serum and Urinary Fibrin/Fibrinogen Degradation Products in Glomerulonephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931732-1

7 January 2021

“Pulse” methylprednisolone therapy in the treatment of severe glomerulonephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931732-1

7 January 2021

Goodpasture's syndrome: a response to nitrogen mustard

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931732-1

7 January 2021

Serious Pulmonary Hemorrhage, Glomerulonephritis, and Massive Steroid Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931732-1

7 January 2021

The prognostic value of some clinical and histological parameters in membranoproliferative glomerulonephritis (MPGN): report of 112 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931732-1

7 January 2021

Poststreptococcal glomerulonephritis. A prospective study in children

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931732-1

7 January 2021

Controlled trial of cyclophosphamide in idiopathic membranous nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931732-1

7 January 2021

Dense Deposits Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931732-1

7 January 2021

Glomerulopathies of neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931732-1

7 January 2021

Treatment of idiopathic membranous nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931732-1

7 January 2021

Membranous glomerulonephritis: long-term serial observations on clinical course and morphology

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931732-1

7 January 2021

Serum immunoglobulins in the nephrotic syndrome. A possible cause of minimal-change nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931732-1

7 January 2021

Chlorambucil treatment of frequently relapsing nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931732-1

7 January 2021

Editorial: Focal glomerular sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931732-1

7 January 2021

Dense deposit disease: a variant of membranoproliferative glomerulonephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931732-1

7 January 2021

Goodpasture's syndrome. Treatment with nephrectomy and renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931732-1

7 January 2021

Progression of Lipoid Nephrosis to Renal Insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931732-1

7 January 2021

Recurrence of idiopathic nephrotic syndrome after renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931732-1

7 January 2021

Immunoglobulin-A distribution in glomerular disease: Analysis of immunofluorescence localization and pathogenetic significance

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931732-1

7 January 2021

Prognosis in steroid-treated idiopathic nephrotic syndrome in adults. Analysis of major predictive factors after ten-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931732-1

7 January 2021

Post-streptococcal glomerulo-nephritis: histopathologic and clinical studies of the acute, subsiding acute and early chronic latent phases

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931732-1

7 January 2021

Plasmapheresis and immunosuppressive agents in antibasement membrane antibody-induced Goodpasture's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931732-1

7 January 2021

Anticoagulants in "irreversible" acute renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931732-1

7 January 2021

Evolution of membranous nephropathy into anti-glomerular-basement-membrane glomerulonephritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931732-1

7 January 2021

Immunopathologic findings in idiopathic renal hematuria

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931732-1

7 January 2021

Goodpasture syndrome treated with immunosuppression and plasma exchange

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931732-1

7 January 2021

Acute glomerulonephritis with prolonged oliguria. An analysis of 29 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931732-1

7 January 2021

Circulating Immune Complexes in Steroid-Responsive Nephrotic Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931732-1

7 January 2021

Adult lipoid nephrosis: clinicopathological correlations

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931732-1

7 January 2021

Immunosuppression and plasma-exchange in the treatment of Goodpasture's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931732-1

7 January 2021

Plasma-exchange and immunosuppression in the treatment of fulminating immune-complex crescentic nephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931732-1

7 January 2021

Immunoglobulin A (IgA) associated glomerulonephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931732-1

7 January 2021

Mesangiocapillary glomerulonephritis: Changes in glomerular morphology with long-term alternate-day prednisone therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931732-1

7 January 2021

IgA-Associated Glomerulonephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931732-1

7 January 2021

Glomerulonephritis (first of three parts).

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931732-1

7 January 2021

TREATMENT OF OLIGURIC GLOMERULONEPHRITIS WITH DIALYSIS AND STEROIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931732-1

7 January 2021

Goodpasture's syndrome: recovery from severe pulmonary hemorrhage after bilateral nephrectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931732-1

7 January 2021

Mesangiocapillary nephritis, partial lipodystrophy, and hypocomplementaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931732-1

7 January 2021

Immunity deficiency in pathogenesis of glomerulonephritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931732-1

7 January 2021

Circulating Immune Complexes in Minimal-Change Nephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931732-1

7 January 2021

Goodpasture's syndrome. A report of five cases and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931732-1

7 January 2021

Recurrent macroscopic hematuria, focal nephritis, and mesangial deposition of immunoglobulin and complement

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931732-1

7 January 2021

Immunosuppressive and Cytotoxic Chemotherapy: Long-Term Complications

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931732-1

7 January 2021

IgA deficiency, epilepsy, and phenytoin treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931732-1

7 January 2021

Remission in Goodpasture's syndrome: report of two patients treated by immunosuppression and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931732-1

7 January 2021

Pathogenesis of lipoid nephrosis: a disorder of T-cell function

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931732-1

7 January 2021

Nephrotic Syndrome Due to Primary Renal Disease in Adults: II. A Controlled Trial of Prednisolone and Azathioprine

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931732-1

7 January 2021

Depression of immunological function in patients treated with phenytoin sodium (sodium diphenylhydantoin).

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931732-1

7 January 2021

Transplantation in mesangiocapillary glomerulonephritis with intramembranous dense "deposits": recurrence of disease

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931732-1

7 January 2021

Cyclophosphamide therapy in adults with minimal-change nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931732-1

7 January 2021

A serum factor in chronic hypocomplementemic hephritis distinct from immunoglobulins and activating the alternate pathway of complement

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931732-1

7 January 2021

Recurrent or persistent hematuria. Sign of mesangial immune-complex deposition

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931732-1

7 January 2021

Carcinoma of the Urinary Bladder in Patients Receiving Cyclophosphamide

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931732-1

7 January 2021

Effect of Heparin on Renal Function in Patients with Oliguria

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931732-1

7 January 2021

Anticoagulant and immunosuppressive drugs in the treatment of severe glomerulonephritis with coagulopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931732-1

7 January 2021

The significance of extracapillary proliferation. Clinicopathological review of 60 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931732-1

7 January 2021

Anti-glomerular basement membrane antibody-induced glomerulonephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931732-1

7 January 2021

Diagnosis of immunopathologic renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931732-1

7 January 2021

Streptococcus-related glomerulonephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931732-1

7 January 2021

Immunoglobulin A nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931732-1

7 January 2021

Mesangiocapillary glomerulonephritis and persistent hypocomplementemia

21

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31732-1

IgA nephropathy: a syndrome of uniform morphology, diverse clinical features and uncertain prognosis

17 December 2022

25

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31732-1

Successful renal transplantation in patients with circulating antibody to glomerular basement membrane: report of two cases

17 December 2022

28

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31732-1

Classification of glomerulonephritis based on morphology

17 December 2022

47

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31732-1

Glomerular and vascular lesions in chronic atrophic pyelonephritis and reflux nephropathy

17 December 2022

65

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31732-1

A controlled trial of cyclophosphamide in the treatment of proliferative glomerulonephritis

17 December 2022

67

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31732-1

GLOMERULAR LESIONS IN THE NEPHROTIC SYNDROME AND THEIR RELATION TO CORTISONE THERAPY

17 December 2022

89

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31732-1

Epidemic glomerulonephritis in Maracaibo. Evidence for progression to chronicity

17 December 2022

97

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31732-1

Focal and segmental hyalinosis

17 December 2022

103

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31732-1

The use of heparin in the treatment of idiopathic rapidly progressive glomerulonephritis

17 December 2022

114

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31732-1

The clinical course of IgA nephropathy in adults

17 December 2022

119

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31732-1

Plasmapheresis in Goodpasture's syndrome with renal failure

17 December 2022

121

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31732-1

Controlled trial of azathioprine in the nephrotic syndrome secondary to idiopathic membranous glomerulonephritis

17 December 2022

125

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31732-1

17 December 2022

Identifiers

0 references

1 reference